RR

Ramakrishnam Raju Gottumukkala

Director DIN 01931363
DIN 01931363 First appointment May 2005
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2005
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramakrishnam Raju Gottumukkala

Data last updated:

Ramakrishnam Raju Gottumukkala was a Director at Omni Physician Ventures Private Limited (from 2012) and Director at Prasad Drugs Private Limited (from 2005).

DIN 01931363
First Appointment 16 May 2005
Oldest Company Age 21 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Apr 20122012Strike Off
Prasad Drugs Private Limited U24239TG2005PTC046238
Director16 May 20052005Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Omni Physician Ventures Private Limited
Prasad Drugs Private Limited
Premium access

Shareholding and investment profile for Ramakrishnam Raju Gottumukkala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramakrishnam Raju Gottumukkala

Ramakrishnam Raju Gottumukkala was first appointed on 16 May 2005 as Director at Prasad Drugs Private Limited. The most recent appointment on record is 13 Apr 2012 at Omni Physician Ventures Private Limited.

Ramakrishnam Raju Gottumukkala held 2 earlier board appointments: Omni Physician Ventures Private Limited (Director, from 13 Apr 2012); Prasad Drugs Private Limited (Director, from 16 May 2005).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available